For patients diagnosed with leukemia, lymphoma, and anemia, a stem cell donation may be their best or only hope for a cure. Yet 70% of patients who need a transplant do not have a matching donor in their family. They depend on Pareto and our supporters to find a match to save their life.
Our founders recognized the need and started the world's first compensated stem cell marketplace. Today, our services and resources extend far beyond. We serve as the hub of a global network that facilitates transplants, treatments, and research.
Pareto's platform boasts the highest donor conversion rate in the industry. However, our work is not done yet. Pareto needs to find a matching donor for all patients who need a transplant. Our innovative efforts are improving diversity, gaining younger donors (those most likely to be called), and better engaging donors to be available when called.
Our global network counts on our groundbreaking technology, bioinformatics, search expertise and unparalleled logistical support at every step to make the transplant possible. From the moment a clinician searches our registry for a donor, to the safe delivery of the cells to a patient for
While the number of all transplants, both autologous and allogeneic, has grown considerably in recent years, our analysis shows that more than half of those who need a transplant never receive one. We partner with our network and other related professional organizations to increase the number of transplant workforce professionals and provide a care delivery system to meet this growing need. We collaborate with clinicians and government officials to deepen the understanding of the coverage needs for all transplant patients. We also conduct studies to understand barriers in access to transplant care.
With our research procurement arm, Pareto facilitates the supply of stem cells for a variety of research institutions across the country in an effort to help develop the